The FDA has approved revisions to the safety labeling for a levonorgestrel-releasing intrauterine contraceptive; linezolid tablets, oral suspension, and injection; and abatacept intravenous infusion.
Medscape Medical News
Source: http://www.medscape.com/pharmacists?src=rss
Medscape Pharmacists Headlines